12.1 Intangible Assets

Intangible Assets: Capitalization, Amortization, and Impairment

Intangible assets are non-financial, non-monetary assets that lack physical substance but provide long-term economic value to an entity. Under US GAAP (specifically ASC 350 and ASC 360), these assets must be carefully classified and accounted for based on their acquisition source and the nature of their useful lives. This section breaks down the rules for capitalization, amortization, and the differing impairment testing models required for definite-life and indefinite-life intangible assets.

---

1. Capitalization vs. Expensing Rules

The accounting treatment for the initial recognition of an intangible asset depends entirely on whether the asset was purchased from an external party or developed internally.

Externally Acquired Intangible Assets

When an entity purchases an intangible asset from an external party, the transaction provides objective evidence of the asset's value. Therefore, US GAAP requires all externally acquired intangible assets to be capitalized at cost. The capitalized cost includes:

• The purchase price paid to the seller.
• Direct legal fees and registration costs incurred to secure the asset.
• Any other costs directly attributable to preparing the asset for its intended use (such as testing or modifications).

If a group of assets is acquired in a single transaction, the cost is allocated to the individual assets based on their relative fair values. If the acquisition occurs as part of a business combination, the assets are recorded at their acquisition-date fair values.

Internally Developed Intangible Assets

In contrast, internally developed intangible assets face highly restrictive capitalization rules due to the lack of objective transaction-based valuation.

• General Expensing Rule: Almost all costs incurred during the development of an internal intangible asset must be expensed as incurred. This includes salaries of employees working on the project, research costs, and prototype testing costs (which are categorized as Research and Development under ASC 730).
• Capitalization Exceptions: An entity is permitted to capitalize only specific, direct costs incurred after the asset's technical feasibility is established and when the legal process begins. Capitalizable costs are limited to:
  • External legal fees incurred to register or successfully defend a patent or trademark.
  • Government and registration filing fees.
  • Document preparation and application costs.

If a legal defense of an intangible asset is unsuccessful, all associated legal fees must be expensed immediately, and the carrying value of the existing intangible asset must be written off as a loss, because the unsuccessful defense indicates the asset has no future economic value.

---

2. Amortization of Definite-Life Intangibles

Intangible assets are classified based on their useful lives. A "definite-life intangible asset" is one with a determinable period of utility (e.g., patents, copyrights, franchises with set terms, customer lists, and covenants not to compete).

Amortization Parameters

• Amortization Period: Definite-life intangibles must be amortized over their estimated useful (economic) lives. However, the amortization period cannot exceed the asset's remaining legal life. For example, if a patent has a legal life of 20 years but is expected to be commercially obsolete in 8 years, it must be amortized over 8 years.
• Amortization Method: The straight-line method is standard unless the entity can demonstrate that another systematic and rational method better reflects the pattern of economic consumption.
• Residual Value: The residual value is assumed to be $0 unless:
  1. A third party has committed to purchase the asset at the end of its useful life.
  2. The residual value can be determined by reference to an active market that is expected to exist at the end of the asset's useful life.

Amortization Journal Entry

Debit: Amortization Expense                      $10,000
  Credit: Accumulated Amortization - Patent (or Patent directly) $10,000

---

3. Impairment of Definite-Life Intangibles (ASC 360)

Definite-life intangible assets are grouped with other long-lived assets (such as PP&E) for impairment testing. They are tested for impairment only when a triggering event occurs (e.g., a significant decrease in market price, a physical change in the asset, or an adverse change in legal factors or the business climate). The test is a two-step process:

Step 1: The Recoverability Test

Compare the carrying value of the asset to the sum of the undiscounted future cash flows expected to be generated by the asset's use and eventual disposal.

• If Undiscounted Cash Flows >= Carrying Value: The asset is recoverable. No impairment is recognized.
• If Undiscounted Cash Flows < Carrying Value: The carrying value is not recoverable. Proceed to Step 2.

Step 2: Measurement of the Impairment Loss

Calculate the impairment loss as the amount by which the carrying value exceeds the asset's fair value (which is typically measured using discounted cash flows or market inputs).

Impairment Loss = Carrying Value - Fair Value

Once an impairment loss is recognized, the reduced carrying value becomes the new cost basis. The asset's remaining useful life is reassessed, and amortization is adjusted prospectively. Reversals of impairment losses are strictly prohibited under US GAAP.

---

4. Impairment of Indefinite-Life Intangibles (ASC 350)

An "indefinite-life intangible asset" is one for which there is no foreseeable limit on the period over which the asset is expected to generate cash flows (e.g., trademarks, trade names, and broadcast licenses).

Amortization and Testing

Indefinite-life intangibles are never amortized. Instead, they must be tested for impairment at least annually, or more frequently if a triggering event occurs.

Testing Methodology

1. Qualitative Assessment (Optional Step 0): An entity can perform a qualitative assessment to determine if it is more likely than not (i.e., a probability > 50%) that the asset's fair value is less than its carrying value. If qualitative factors suggest no impairment, the quantitative test is bypassed. Otherwise, the entity must perform the quantitative test.

2. Quantitative Test: Compare the fair value of the asset directly to its carrying value.

   • If Fair Value >= Carrying Value: No impairment.
   • If Fair Value < Carrying Value: Impairment loss is recognized.

   Impairment Loss = Carrying Value - Fair Value

[!IMPORTANT] Because indefinite-life intangibles have no set useful life, their cash flows are projected to continue infinitely. Therefore, there is no undiscounted cash flow recoverability test (Step 1) for indefinite-life assets under US GAAP. Carrying value is compared directly to fair value.

---

5. Comparison: Definite-Life vs. Indefinite-Life Intangibles

---

6. Real-World Worked Examples

Example 1: Definite-Life Patent Accounting

On January 1, 2026, Gamma Inc. purchased a patent from an inventor for $400,000 and paid $50,000 in legal fees to register the transfer. The patent has a remaining legal life of 12 years but is expected to be useful for only 10 years.

• Initial Capitalization: Capitalize at cost of $400,000 + $50,000 = $450,000.
• Annual Amortization: Amortize over 10 years (shorter of useful or legal life). Annual Amortization = $450,000 / 10 = $45,000 per year
• Impairment Assessment: On December 31, 2028 (after 3 years of amortization), the carrying value of the patent is: Carrying Value = $450,000 - ($45,000 * 3) = $315,000 At this date, a competitor releases a superior product, triggering an impairment review. Gamma estimates the patent's undiscounted future cash flows will be $290,000, and its fair value (discounted cash flows) is $240,000.
  • Recoverability Test: Since Carrying Value ($315,000) exceeds Undiscounted Cash Flows ($290,000), the patent is impaired.
  • Measurement: Impairment Loss = Carrying Value ($315,000) - Fair Value ($240,000) = $75,000.
  • Journal Entry:

    Debit: Loss on Impairment of Patent       $75,000
      Credit: Accumulated Amortization - Patent  $75,000
    

  • Subsequent Accounting: The new carrying value of $240,000 is amortized over the patent's remaining 7 years of useful life at $34,286 per year.

Example 2: Indefinite-Life Trademark Accounting

Delta Corp. has a registered trademark with a carrying value of $150,000 that is not amortized. On December 31, 2026, Delta performs its annual impairment test. Due to a decline in brand reputation, Delta estimates the trademark's fair value has dropped to $110,000.

• Impairment Test: Because it is an indefinite-life asset, Delta bypasses the recoverability test and directly compares carrying value to fair value. Impairment Loss = $150,000 - $110,000 = $40,000
• *Journal Entry:

  Debit: Loss on Impairment of Trademark    $40,000
    Credit: Trademark                       $40,000
  

  The trademark's carrying value is written down to $110,000. In 2027, if brand value recovers, no reversal of the $40,000 loss is permitted.